United Therapeutics Overview
Latest PEG ratio for United Therapeutics: 224.57 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow224.57
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, UTHR shows a PEG ratio of 224.57. That is above the Healthcare sector average of 2.56. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.56. United Therapeutics is at 224.57, which is higher that average. That is roughly 8673.2% above the sector mean. Use the comparison chart on this page to see how UTHR stacks up against individual peers as well.
Investors watch UTHR's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. United Therapeutics's latest reading is 224.57. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has United Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 224.57) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.56, while UTHR is at 224.57. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
